pegylated liposomal doxorubicin

single use of pegylated liposomal doxorubicin has been reported to be safe and effective with varying treatment in patients with advanced hepatocellular carcinoma

-

Organic Chemicals: 42

-

Hydrocarbons: 362

-

Cyclic Hydrocarbons: 3

-

Aromatic Hydrocarbons: 121

-

Aromatic Polycyclic Hydrocarbons: 617

-

Naphthacenes

-

Anthracyclines: 1388

-

Daunorubicin: 1771

-

Doxorubicin: 15671

*

pegylated liposomal doxorubicin: 339

-

Alcohols: 320

-

Glycols: 38

-

Ethylene Glycols: 2

-

Polyethylene Glycols: 1485

*

pegylated liposomal doxorubicin: 339

-

Macromolecular Substances: 43

-

Polymers: 3257

-

Polyethylene Glycols: 1485

*

pegylated liposomal doxorubicin: 339

-

Biomedical and Dental Materials

-

Polymers: 3257

-

Polyethylene Glycols: 1485

*

pegylated liposomal doxorubicin: 339

-

Technology, Industry, and Agriculture

-

Manufactured Materials

-

Biomedical and Dental Materials

-

Polymers: 3257

-

Polyethylene Glycols: 1485

*

pegylated liposomal doxorubicin: 339

-

Polycyclic Compounds: 59

-

Aromatic Polycyclic Hydrocarbons: 617

-

Naphthacenes

-

Anthracyclines: 1388

-

Daunorubicin: 1771

-

Doxorubicin: 15671

*

pegylated liposomal doxorubicin: 339

-

Carbohydrates: 2945

-

Glycosides: 357

-

Aminoglycosides: 1129

-

Anthracyclines: 1388

-

Daunorubicin: 1771

-

Doxorubicin: 15671

*

pegylated liposomal doxorubicin: 339

Ping-Chin Lai Selected Research

Articles by Research Topic

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure